BridgeBio is significantly improved the development of an new solution for amyloid heart disease, leveraging the compound. Early clinical results suggests potential outcomes for patients diagnosed by this debilitating https://bridgebio834518.idblogmaker.com/40819370/company-progresses-attr-cm-therapy-with-the-drug